• Info
  • Insider Ownership

Insider Trading & Ownership of Shin Nippon Biomedical Laboratories, Ltd.

Location
Kagoshima, Japan
Summary
The estimated value of insider holdings of Shin Nippon Biomedical Laboratories, Ltd. is at least $9,995,906 dollars as of 08 Jun 2023. Shin Nippon Biomedical Laboratories, Ltd. is the 10%+ Owner of Satsuma Pharmaceuticals, Inc. and owns shares of Satsuma Pharmaceuticals, Inc. stock worth about $10M.
Signature
Shin Nippon Biomedical Laboratories, Ltd., By: /s/ Shinji Nitanda, Director
All Insider Reports
All Insider Reports

Notify me when Shin Nippon Biomedical Laboratories, Ltd. files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Shin Nippon Biomedical Laboratories, Ltd.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
STSA Satsuma Pharmaceuticals, Inc. 10%+ Owner $9,995,906 06 Jun 2023

Insider Transactions Reported by Shin Nippon Biomedical Laboratories, Ltd.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.